Molecular circuits of resolution in airway inflammation.

TheScientificWorldJournal
T Carlo, B D Levy

Abstract

Inflammatory diseases of the lung are common, cause significant morbidity, and can be refractory to therapy. Airway responses to injury, noxious stimuli, or microbes lead to leukocyte recruitment for host defense. As leukocytes respond, they interact with lung resident cells and can elaborate specific mediators that are enzymatically generated from polyunsaturated fatty acids via transcellular biosynthesis. These bioactive, lipid-derived, small molecules serve as agonists at specific receptors and are rapidly inactivated in the local environment. This review will focus on the biosynthesis, receptors, cellular responses, and in vivo actions of lipoxins, resolvins, and protectins as exemplary molecular signaling circuits in the airway that are anti-inflammatory and proresolving.

References

Jun 1, 1992·The American Review of Respiratory Disease·P E ChristieT H Lee
Aug 15, 1995·Annals of Internal Medicine·J H ShelhamerS I Rennard
Jul 1, 1994·The Journal of Experimental Medicine·S FioreC N Serhan
Jul 1, 1993·The Journal of Clinical Investigation·S P ColganJ L Madara
Nov 14, 1997·Nature·B D LevyC N Serhan
Jun 9, 1999·Biochemistry·C M SchaldachL F Bjeldanes
May 4, 2000·The New England Journal of Medicine·L B Ware, M A Matthay
May 12, 2000·American Journal of Respiratory and Critical Care Medicine·J BousquetA M Vignola
Aug 10, 2000·The European Respiratory Journal·M SanakA Szczeklik
Feb 15, 2001·The New England Journal of Medicine·W W Busse, R F Lemanske
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·Iolanda M FierroCharles N Serhan
Aug 13, 2002·Nature Medicine·Bruce D LevyCharles N Serhan
Dec 24, 2002·American Journal of Respiratory Cell and Molecular Biology·Jay K KollsAlistair J Ramsay
Feb 6, 2004·The New England Journal of Medicine·Steven D FreedmanBrian P O'Sullivan
Mar 23, 2004·Nature Immunology·Christopher L KarpNicos A Petasis
Jul 24, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yoshinori SatoIzumi Hayashi
Jan 8, 2005·The Journal of Allergy and Clinical Immunology·Isabelle VachierPascal Chanez
Mar 9, 2005·The Journal of Experimental Medicine·Makoto AritaCharles N Serhan
Jun 18, 2005·American Journal of Respiratory and Critical Care Medicine·Bruce D LevyUNKNOWN Severe Asthma Research Program, National Heart, Lung, and Blood Institute
Jun 28, 2005·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Christopher L KarpNicos A Petasis
Jul 28, 2005·Prostaglandins, Leukotrienes, and Essential Fatty Acids·B D Levy
Feb 9, 2006·The Journal of Biological Chemistry·Koichi FukunagaBruce D Levy
Mar 28, 2006·The American Journal of Pathology·Caroline BonnansBruce D Levy
Mar 29, 2006·The Journal of Experimental Medicine·Caroline BonnansBruce D Levy
Sep 14, 2006·Pharmacological Reviews·Nan ChiangCharles Brink
Dec 16, 2006·European Journal of Pharmacology·Dae Yong KimJai Youl Ro
Apr 14, 2007·American Journal of Respiratory Cell and Molecular Biology·Krishnan ParameswaranP Gerard Cox

❮ Previous
Next ❯

Citations

Nov 15, 2012·Respiratory Research·Aina NogueraAlvar Agustí
May 12, 2012·Prostaglandins & Other Lipid Mediators·David M AronoffPeter Mancuso
Feb 6, 2021·Cellular and Molecular Life Sciences : CMLS·Wan-Chi Lin, Michael B Fessler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

The Journal of Pediatrics
Sharon A McGrath-MorrowHoward M Lederman
Archives of Disease in Childhood
Thomas O CrawfordHoward M Lederman
Seminars in Pediatric Neurology
Thomas O Crawford
The Journal of Pediatrics
Maureen A Lefton-GreifHoward M Lederman
© 2021 Meta ULC. All rights reserved